Last updated on August 2019

A Study of Lasmiditan (LY573144) Over Four Migraine Attacks


Brief description of study

The reason for this study is to see how effective and safe the study drug known as lasmiditan is in the acute treatment of 4 migraine attacks with or without aura.

Clinical Study Identifier: NCT03670810

Find a site near you

Start Over

Georgetown University Hospital

Washington, WA United States
  Connect »

Diamond Headache Clinic

Chicago, IL United States
  Connect »

StudyMetrix Research, LLC

Saint Peters, MO United States
  Connect »

Nevada Headache Institute

Las Vegas, NV United States
  Connect »

Dent Neurological Institute

Amherst, NY United States
  Connect »

Northwell Health

Great Neck, NY United States
  Connect »

Island Neuro Associates,PC

Plainview, NY United States
  Connect »

AKH

Wien, Austria
  Connect »

APHM H pital de la Timone

Marseille Cedex 5, France
  Connect »

CHU St Etienne Hopital Nord

Saint Etienne Cedex 2, France
  Connect »

Valeomed Kft.

Esztergom, Hungary
  Connect »

Isala Klinieken

Zwolle, Netherlands
  Connect »

University Headache Clinic

Moscow, Russian Federation
  Connect »

Medis Priokskiy

Nizhny Novgorod, Russian Federation
  Connect »

Hospital Universitari de Bellvitge

L'Hospitalet de Llobregat, Spain
  Connect »

Kantonsspital Luzern

Luzern 16, Switzerland
  Connect »

Kantonsspital St. Gallen

St. Gallen, Switzerland
  Connect »

Rehaclinic Bad Zurzach

Bad Zurzach, Switzerland
  Connect »

Kings College Hospital

London, United Kingdom
  Connect »

Royal Stoke University Hospital

Stoke-on-Trent, United Kingdom
  Connect »

Re-Cognition Health Ltd

Guildford, United Kingdom
  Connect »

Re-Cognition Health Ltd

Birmingham, United Kingdom
  Connect »